Vaccines Formulation and Final Fill
Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements.
ISO-certified manufacturing critical to vaccine final fill
To meet these requirements, products must be prepared in an ISO Class 5 environment and meet USP71, USP85 and USP758 requirements to be sterile, pyrogen-free and particulate-free. They must also be validated for use in storage of frozen or lyophilized drug product and for compatibility with the protein and excipients in final formulation.
Not only do we offer a large range of excipients that are used in drug product formulation — including adjuvants, stabilizers, preservatives and bulking agents — but our scientists can also support your formulation development. We also offer production water processed and meeting testing requirements in accordance with USP Water-for-Injection (WFI) regulations used in drug product manufacturing and as a diluent.
Explore solutions for final fill of vaccines
Discover Avantor's fluid handling solutions and access literature, technical articles and videos.
With cGMP and cGDP chemical and excipients manufacturing, see how Avantor’s offerings can help speed time-to-market.
Learn how Avantor Services bioprocessing specialists can help optimize your upstream and downstream operations.
Avantor’s environmental control solutions provide customized support for exactly how your facility operates.
Explore product choices for final fill for vaccines
Ready to move science forward?
We’re here to help.